Bibliography
- HANCOCK REW, CHAPPLE DS: Peptide antibiotics. Antimicrob. Agents Chemother. (1999) 43:1317–1323.
- HANCOCK REW, LEHRER RI: Cationic peptides: a new source of antibiotics. Trends Biotech. (1998) 16:82–88.
- BOMAN HG: Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol (1995) 13:61–92.
- HANCOCK REW: The therapeutic potential of cationic peptides. Exp. Opin. Invest. Drugs. (1998) 7:167–174.
- ZHANG L, BENZ R, HANCOCK REW: Influence of proline residues on the antibacterial and synergistic activities of a-helical peptides. Biochemistry (1999) 38:8102–8111.
- ROZEK A, FRIEDRICH CL, HANCOCK REW: Structure ofthe bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. (2000) (In Press).
- FRIEDRICH C, SCOTT MG, KARUNARATNE N, YAN H, HANCOCK REW: Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob. Agents Chemother. (1999) 43:1274–1276.
- STEINBERG DA, HURST MA, FUJII CA et al.: Pr otegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. (1997) 41:1738–1742.
- SCHWAB U, GILLIGAN P, JAYNES PJ, HENKE D: In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. AntimE crob. Agents Chemother. (1999) 43:1435–1440.
- BALS R, WEINER DJ, MEEGALLA RL, WILSON JM: Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. (1999) 108:1113–1117.
- AHMAD I, PERKINS WR, LUPAN DM et al: Iiposomal entrapment of the neutrophil-derived peptide indoli-cidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta (1995) 1237:109–114.
- VINNICOMBE J, STAMEY TA: The relative nephr otoxici-ties of polymyxin B sulfate, sodium sulfomethyl-polymyxin B, sodium sulfomethyl-colistin (colymycin) and neomycin sulfate. Investig. Urol (1969) 6:505–519.
- LAMB HM, WISEMAN LR: Pexiganan acetate. Drugs (1998)56:1047–1052.
- JENSEN, T, PEDERSEN SS, GARNE S et al.: Colistin inhala-tion therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J. AntimE crob. Chemother. (1987) 19:831–838.
- CONWAY, SP, POND MN, WATSON A, ETHERINGTON C, ROBEY HL, GOLDMAN MH: Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax (1997) 52:987–993.
- WEINSTEIN, J, ALFONSO A, MOSS E, JR, MILLER GH: Selective chemical modifications of polymyxin B. Bioorg. Med. Chem. (1998) 8:3391–3396.
- KONDAJEWSKI, LH, FARMER SW, WISHART DS, KAY CM, HANCOCK REW, HODGES RS: Effect of ring size of gramicidin S analogs on structure, antibacterial and hemolytic activity. J Biol. Chem. (1996) 271:25261–25268.
- LOURY, D, EMBREE JR, STEINBERG DA, SONIS ST, FIDDES JC: Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg. Oral Med. Oral Path. Oral Radio]. Endod (1999) 87:544–551.
- PAQUETTE, DW, WATERS GS, STEFANIDOU VL et al.:Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. j Clin. Periodontol (1997) 24:216–222.
- GIROIR, BP, QUINT PA, BARTON P et al.: Preliminaryevaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet (1997) 350:1439–1443.